JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India.
The last earnings update was 54 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
JHS Svendgaard Laboratories. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
JHS Svendgaard Laboratories's
is considered below, and whether this is a fair price.
Price based on past earnings
JHS Svendgaard Laboratories's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as JHS Svendgaard Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Personal Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
JHS Svendgaard Laboratories
expected to grow at an
Unable to compare JHS Svendgaard Laboratories's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare JHS Svendgaard Laboratories's earnings growth to the India market average as no estimate data is available.
Unable to compare JHS Svendgaard Laboratories's revenue growth to the India market average as no estimate data is available.
Unable to determine if JHS Svendgaard Laboratories is high growth as no earnings estimate data is available.
Unable to determine if JHS Svendgaard Laboratories is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
JHS Svendgaard Laboratories's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
JHS Svendgaard Laboratories
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
JHS Svendgaard Laboratories's finances.
The net worth of a company is the difference between its assets and liabilities.
JHS Svendgaard Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
JHS Svendgaard Laboratories's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
JHS Svendgaard Laboratories's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
Debt is covered by short term assets, assets are 17.5x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Did You Miss JHS Svendgaard Laboratories's (NSE:JHS) 87% Share Price Gain?
View our latest analysis for JHS Svendgaard Laboratories Because JHS Svendgaard Laboratories is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. … When a company doesn't make profits, we'd generally expect to see good revenue growth. … Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.
Can We See Significant Insider Ownership On The JHS Svendgaard Laboratories Limited (NSE:JHS) Share Register?
See our latest analysis for JHS Svendgaard Laboratories NSEI:JHS Ownership Summary, July 5th 2019 What Does The Lack Of Institutional Ownership Tell Us About JHS Svendgaard Laboratories? … Insider Ownership Of JHS Svendgaard Laboratories While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. … Private Company Ownership We can see that Private Companies own 3.5%, of the shares on issue.
Do Institutions Own JHS Svendgaard Laboratories Limited (NSE:JHS) Shares?
Every investor in JHS Svendgaard Laboratories Limited (NSE:JHS) should be aware of the most powerful shareholder groups. … JHS Svendgaard Laboratories is not a large company by global standards. … Taking a look at our data on the ownership groups (below), it's seems that.
Why We’re Not Keen On JHS Svendgaard Laboratories Limited’s (NSE:JHS) 0.06% Return On Capital
Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … What is Return On Capital Employed (ROCE)? … ROCE measures the 'return' (pre-tax profit) a company generates from capital employed in its business.
Read This Before Judging JHS Svendgaard Laboratories Limited's (NSE:JHS) ROE
We'll use ROE to examine JHS Svendgaard Laboratories Limited (NSE:JHS), by way of a worked example. … See our latest analysis for JHS Svendgaard Laboratories? … Return on Equity = Net Profit ÷ Shareholders' Equity
What Kind Of Shareholder Appears On The JHS Svendgaard Laboratories Limited's (NSE:JHS) Shareholder Register?
Every investor in JHS Svendgaard Laboratories Limited (NSE:JHS) should be aware of the most powerful shareholder groups. … JHS Svendgaard Laboratories is not a large company by global standards. … See our latest analysis for JHS Svendgaard Laboratories
What You Must Know About JHS Svendgaard Laboratories Limited's (NSE:JHS) Return on Equity
and looking to gauge the potential return on investment in JHS Svendgaard Laboratories Limited (NSE:JHS). … JHS Svendgaard Laboratories Limited (NSE:JHS) generated a below-average return on equity of 14.96% in the past 12 months, while its industry returned 26.03%. … An investor may attribute an inferior ROE to a relatively inefficient performance, and whilst this can often be the case, knowing the nuts and bolts of the ROE calculation may change that perspective and give you a deeper insight into JHS's past performance.
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture products under the Dr. Gold and Aquawhite brands. It also provides contract manufacturing services for oral care products of other brands; and operates a chain of dental clinics, as well as is involved in retail trade in stores. The company also sells its products through its Website, aquawhite.in. It also exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is headquartered in New Delhi, India.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.